CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group (Q45782918)
scientific article
Language:
Current Data About CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group
(P31) (Q13442814)
(P248)
(P698) 7930717
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/7930717

(P50) (Q37375437)
(P1545) 2
(P248)
(P698) 7930717
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/7930717

(Q89374231)
(P1545) 8
(P1932) Margolick JB
(P248)
(P698) 7930717
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/7930717

(P304) 775-781
(P248)
(P698) 7930717
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/7930717

(P407) (Q1860)

(P433) 4
(P248)
(P698) 7930717
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/7930717

(P478) 170
(P248)
(P698) 7930717
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/7930717

(P577) Saturday, October 1, 1994
(P248)
(P698) 7930717
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/7930717

(P921) (Q12199)

(Q715347)

(Q2141450)
(P887)

(P1104) 7
(P887)

(P1433) (Q4051141)
(P248)
(P698) 7930717
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/7930717

(P1476) "CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group" (language: en)
(P248)
(P698) 7930717
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/7930717

(P2093) Giorgi JV
(P1545) 1
(P248)
(P698) 7930717
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/7930717

Hirji K
(P1545) 3
(P248)
(P698) 7930717
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/7930717

Chou CC
(P1545) 4
(P248)
(P698) 7930717
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/7930717

Hultin LE
(P1545) 5
(P248)
(P698) 7930717
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/7930717

O'Rourke S
(P1545) 6
(P248)
(P698) 7930717
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/7930717

Park L
(P1545) 7
(P248)
(P698) 7930717
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/7930717

Ferbas J
(P1545) 9
(P248)
(P698) 7930717
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/7930717

Phair JP
(P1545) 10
(P248)
(P698) 7930717
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/7930717

other details
description scientific article

External Links
(P356) 10.1093/INFDIS/170.4.775
(P698) 7930717